INDUCTION OF POTENT HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES FOLLOWING DIRECT-INJECTION OF DNA ENCODING THE HIV TYPE-1 ENV AND REV GENE-PRODUCTS

被引:104
作者
OKUDA, K
BUKAWA, H
HAMAJIMA, K
KAWAMOTO, S
SEKIGAWA, KI
YAMADA, Y
TANAKA, SI
ISHII, N
AOKI, I
NAKAMURA, M
YAMAMOTO, H
CULLEN, BR
FUKUSHIMA, J
机构
[1] YOKOHAMA CITY UNIV,SCH MED,DEPT ORAL & MAXILLOFACIAL SURG,YOKOHAMA,KANAGAWA 236,JAPAN
[2] YOKOHAMA CITY UNIV,SCH MED,DEPT INTERNAL MED,YOKOHAMA,KANAGAWA 236,JAPAN
[3] YOKOHAMA CITY UNIV,SCH MED,DEPT DERMATOL,YOKOHAMA,KANAGAWA 236,JAPAN
[4] YOKOHAMA CITY UNIV,SCH MED,DEPT PATHOL,YOKOHAMA,KANAGAWA 236,JAPAN
[5] TOYAMA MED & PHARMACEUT UNIV,LAB ANIM RES CTR,TOYAMA 93001,JAPAN
[6] DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710
[7] DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710
关键词
D O I
10.1089/aid.1995.11.933
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DNA vaccines have the potential of giving rise to a potent cell-mediated immune response by inducing intracellular synthesis and subsequent antigenic presentation of encoded antigens. We have tested a DNA vaccine specific for human immunodeficiency virus type 1 (HIV-1) by the injection of animals with expression plasmids encoding the HIV-1 envelope protein and the Rev regulatory protein, Injection of both plasmids into mice, rabbits, or macaques was found to induce high levels of specific antibodies capable of efficiently inhibiting both HIV-1 infection and envelope-mediated cell fusion, A readily detectable delayed-type hypersensitivity (DTH) response was demonstrable in injected mice and lymphocytes derived from these mice proliferated in response to an HIV-1 envelope V3 loop-specific peptide. Interestingly, the injected mice or macaques also developed a strong cytotoxic T lymphocyte (CTL) response against target cells pulsed with the V3 peptide. Taken together, these data demonstrate that injection of HIV-1 gene expression plasmids can induce potent humoral and cell-mediated immune responses and suggest that DNA vaccines may prove to be significantly beneficial as a means of immunizing against HIV-1.
引用
收藏
页码:933 / 943
页数:11
相关论文
共 57 条
[1]   HGP-30, A SYNTHETIC ANALOG OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) P17, IS A TARGET FOR CYTOTOXIC LYMPHOCYTES IN HIV-INFECTED INDIVIDUALS [J].
ACHOUR, A ;
PICARD, O ;
ZAGURY, D ;
SARIN, PS ;
GALLO, RC ;
NAYLOR, PH ;
GOLDSTEIN, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7045-7049
[2]   HUMAN DYSTROPHIN EXPRESSION IN MDX MICE AFTER INTRAMUSCULAR INJECTION OF DNA CONSTRUCTS [J].
ACSADI, G ;
DICKSON, G ;
LOVE, DR ;
JANI, A ;
WALSH, FS ;
GURUSINGHE, A ;
WOLFF, JA ;
DAVIES, KE .
NATURE, 1991, 352 (6338) :815-818
[3]   PROSPECTS FOR A VACCINE AGAINST HIV [J].
ADA, G .
NATURE, 1989, 339 (6223) :331-332
[4]  
BOLOGNESI DP, 1989, JAMA-J AM MED ASSOC, V61, P3007
[5]   IMMUNE-RESPONSE AND EPITOPE MAPPING OF A CANDIDATE HIV-1 P17 VACCINE-HGP30 [J].
BOUCHER, CAB ;
KRONE, WJA ;
GOUDSMIT, J ;
MELOEN, RH ;
NAYLOR, PH ;
GOLDSTEIN, AL ;
SUN, DK ;
SARIN, PS .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1990, 4 (01) :43-47
[6]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[7]   HELPER T-CELL ANTIGENIC SITE IDENTIFICATION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME VIRUS GP120 ENVELOPE PROTEIN AND INDUCTION OF IMMUNITY IN MICE TO THE NATIVE PROTEIN USING A 16-RESIDUE SYNTHETIC PEPTIDE [J].
CEASE, KB ;
MARGALIT, H ;
CORNETTE, JL ;
PUTNEY, SD ;
ROBEY, WG ;
OUYANG, C ;
STREICHER, HZ ;
FISCHINGER, PJ ;
GALLO, RC ;
DELISI, C ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) :4249-4253
[8]   EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC T-HELPER CELL RESPONSES BEFORE DETECTION OF INFECTION BY POLYMERASE CHAIN-REACTION AND SERUM ANTIBODIES [J].
CLERICI, M ;
BERZOFSKY, JA ;
SHEARER, GM ;
TACKET, CO .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) :178-182
[9]   CELL-MEDIATED IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN SERONEGATIVE HOMOSEXUAL MEN WITH RECENT SEXUAL EXPOSURE TO HIV-1 [J].
CLERICI, M ;
GIORGI, JV ;
CHOU, CC ;
GUDEMAN, VK ;
ZACK, JA ;
GUPTA, P ;
HO, HN ;
NISHANIAN, PG ;
BERZOFSKY, JA ;
SHEARER, GM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1012-1019
[10]  
CLERICI M, 1991, J IMMUNOL, V146, P2214